MDDA are supported and assisted in our work by a number of organisations who partner with us. We believe it is important to establish and maintain relationships with commercial companies in order to enhance health outcomes for IEM patients. Each partner provides a different type of support or assistance. Partnering and collaborating with us demonstrates their positive commitment in supporting the Australian IEM community.
If your business or corporation is interested in becoming a sponsor/supporter please contact us, we have a number of opportunities where you can support us.
BioMarin has been a leading corporate funder of MDDA for a number of years. Their commitment and generosity has enabled MDDA to expand our services, programs and campaigns to the wider IEpM community.
BioMarin is a world leader in developing and commercialising innovative biopharmaceuticals for rare diseases driven by genetic causes.
Menarini Australia has been a long-term valued supporter of the MDDA. Their financial support has enabled us to provide opportunities to the IEM community to improve programs, projects and events.
Menarini Australia is proud of its commitment to supporting the treatment of rare diseases through the provision of highly targeted drugs that assist just a handful of patients.
Nutricia Australia have been actively supporting the MDDA for over 15 years. We appreciate their on-going partnership and collaboration and look forward to working on many more projects together.
Nutricia Australia is a division of the French multinational company, Group Danone. Nutricia is recognised as the leader in specialised nutrition and operates in a unique position in the global market as the only company whose entire business is based on nutritional products and support for all age groups.
Vitaflo have generously been supporting MDDA for over 15 years. We are grateful that they choose to support us in our mission to improve the health and wellbeing for the IEpM community.
For over 20 years, Vitaflo® has been at the forefront of developing innovative specialised clinical nutrition products for Inborn Errors of Metabolism (IEM). We work in partnership with health care professionals, patients and their families, in order to create products that combine the best of cutting-edge research with the lifestyle demands of modern living, ensuring the most acceptable products are available.
We look forward to an on-going partnership and future collaborations with PTC Therapies.
PTC Therapies is an established global biopharmaceutical company that delivers transformative therapies for people living with rare diseases.
Cortex Health and their passionate employees have been supporting MDDA over several years. They make the best Pancake breakfasts at our annual family conference!
Cortex Health is an Australian based distributor of highly specialised medical products and medical foods.